MedTrace Logo

Preparing for Adolescent HIV Vaccine Trials in South Africa:

NCT00944879 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1400

Last updated 2009-08-17

No results posted yet for this study

Summary

This study will use the licensed HPV vaccine, Gardasil, as a surrogate for an HIV vaccine, in order to explore some of the ethico-legal,psycho-social and logistical challenges involved in running an HIV vaccine trial in adolescents.

Conditions

  • HIV Infection
  • HIV Infections

Sponsors & Collaborators

  • European and Developing Countries Clinical Trials Partnership (EDCTP)

    collaborator OTHER_GOV

  • Merck Sharp & Dohme LLC

    collaborator INDUSTRY

  • Desmond Tutu HIV Centre

    lead OTHER

Principal Investigators

  • Linda-Gail Bekker, MBChB PhD · Desmond Tutu HIV Centre

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • South Africa

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00944879 on ClinicalTrials.gov